APA (7th ed.) Citation

OC, F., HM, B., S, R., R, H., D, D., M, L., . . . MC, J. (2019). CD19 CAR T cell product and disease attributes predict leukemia remission durability. The Journal of clinical investigation, 129(5), 2123. https://doi.org/10.1172/JCI125423

Chicago Style (17th ed.) Citation

OC, Finney, et al. "CD19 CAR T Cell Product and Disease Attributes Predict Leukemia Remission Durability." The Journal of Clinical Investigation 129, no. 5 (2019): 2123. https://doi.org/10.1172/JCI125423.

MLA (9th ed.) Citation

OC, Finney, et al. "CD19 CAR T Cell Product and Disease Attributes Predict Leukemia Remission Durability." The Journal of Clinical Investigation, vol. 129, no. 5, 2019, p. 2123, https://doi.org/10.1172/JCI125423.